Do I need longer between hard sessions because I am older?
Not for muscle damage: across 36 studies, strength loss 24-72 h after damaging exercise did not differ by age; soreness and CK were lower in the older.
Fernandes and colleagues ran a PRISMA-accordant meta-analysis comparing exercise-induced muscle damage in older and younger adults. They searched Google Scholar, PubMed and SPORTDiscus in June 2023 with terms for age (including "masters" and "veteran") and muscle damage, soreness or creatine kinase.
Of 1092 titles, 36 studies compared a younger with an older group after an exercise bout. Outcomes were muscle function, muscle soreness and creatine kinase, pooled as standardised mean differences with an inverse-variance random-effects model. The change in muscle function at 24 h and 72 h, and its peak change, did not differ between old and young (SMD −0.16 to −0.35).
Soreness was greater in the younger adults for every comparison (SMD −0.34 to −0.62), and creatine kinase was greater in the younger at 24 h (SMD −0.32) and at its peak (SMD −0.32).
The abstract adds that a relationship between sex and peak muscle-function change was "evident for males (SMD = −0.45), but not females (SMD = −0.44)"; with near-identical SMDs and no intervals or study counts, this is not evidence that men and women differ, and it may mean the older-younger difference at peak reached significance only in the male studies (our reading); all other meta-regressions were non-significant.
The authors conclude that advancing age is not associated with greater symptoms of muscle damage and that older adults can pursue regular activity without concern for greater damage.
Our reading: pooled support for the base's line that a masters athlete's gap after damaging work is widened on what monitoring shows, not on age; it does not show that older athletes recover endurance quality as fast, which was not measured.
Protocol
Key Results
Older vs younger adults after the same damaging exercise (abstract; negative SMD = smaller change in the older group, as the abstract's soreness and CK statements imply):
| Outcome | Time point | SMD (older vs younger) | Result |
|---|---|---|---|
| Muscle function (strength or function loss) | 24 h, 72 h, peak | −0.16 to −0.35 | not different |
| Marker — muscle soreness | all comparisons | −0.34 to −0.62 | greater in the younger |
| Marker — creatine kinase | 24 h | −0.32 | greater in the younger |
| Marker — creatine kinase | peak | −0.32 | greater in the younger |
| Meta-regression: peak muscle-function change, men | — | −0.45 | relationship "evident" |
| Meta-regression: peak muscle-function change, women | — | −0.44 | not evident |
| All other meta-regressions | — | — | non-significant |
Mechanisms
Practical Application
Limitations
How this entry was checked and changed
a meta-analysis of 36 studies, but the included studies are age-group comparisons (age cannot be randomised), the outcomes are markers and muscle function rather than performance, and heterogeneity, participant numbers and confidence intervals are not in the abstract; read from the abstract (the full text is not open; OpenAlex lists a Liverpool John Moores accepted version not marked open access, with only an ORCID link)